Burden and Excess Risk of Adverse Outcomes in Patients With Type 1 Diabetes Using KDIGO Classification: A National Cohort Study
A progressively increasing burden of all studied adverse outcomes was observed with advancing KDIGO categories. Even individuals with preserved eGFR and normoalbuminuria (G2A1), conventionally perceived as non-CKD, had an excess risk for all outcomes.
Authors
- Seema Baid‐Agrawal (ORCID: https://orcid.org/0000-0001-8192-1079)
- Hanne Krage Carlsen (ORCID: https://orcid.org/0000-0003-1656-9624)
- Björn Eliasson (ORCID: https://orcid.org/0000-0003-2569-4160)
- Kianoush Makvandi (ORCID: https://orcid.org/0009-0003-8261-6043)
Institutions
- Sahlgrenska University Hospital (SE)
- Centre of Registers Vastra Gotaland (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-11-20
- DOI
- https://doi.org/10.2337/dc24-0908
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Amgen
- Eli Lilly and Company
- Sanofi
- Novo Nordisk